Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC vs ASTRAZENECA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC ASTRAZENECA PHARMA FDC/
ASTRAZENECA PHARMA
 
P/E (TTM) x 23.9 95.5 25.0% View Chart
P/BV x 3.5 22.7 15.4% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 FDC   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    FDC
Mar-23
ASTRAZENECA PHARMA
Mar-23
FDC/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs3183,620 8.8%   
Low Rs2292,438 9.4%   
Sales per share (Unadj.) Rs107.5401.2 26.8%  
Earnings per share (Unadj.) Rs11.739.7 29.4%  
Cash flow per share (Unadj.) Rs14.046.2 30.4%  
Dividends per share (Unadj.) Rs016.00 0.0%  
Avg Dividend yield %00.5 0.0%  
Book value per share (Unadj.) Rs119.5234.4 51.0%  
Shares outstanding (eoy) m165.9125.00 663.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.57.5 33.7%   
Avg P/E ratio x23.476.3 30.7%  
P/CF ratio (eoy) x19.565.5 29.7%  
Price / Book Value ratio x2.312.9 17.7%  
Dividend payout %040.3 0.0%   
Avg Mkt Cap Rs m45,36875,718 59.9%   
No. of employees `000NANA-   
Total wages/salary Rs m3,9092,591 150.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m17,83810,030 177.8%  
Other income Rs m512261 196.3%   
Total revenues Rs m18,35010,291 178.3%   
Gross profit Rs m2,4961,249 199.8%  
Depreciation Rs m389163 239.5%   
Interest Rs m416 648.7%   
Profit before tax Rs m2,5781,341 192.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m640348 183.8%   
Profit after tax Rs m1,938993 195.2%  
Gross profit margin %14.012.5 112.4%  
Effective tax rate %24.826.0 95.6%   
Net profit margin %10.99.9 109.8%  
BALANCE SHEET DATA
Current assets Rs m14,4319,359 154.2%   
Current liabilities Rs m7,2964,844 150.6%   
Net working cap to sales %40.045.0 88.8%  
Current ratio x2.01.9 102.4%  
Inventory Days Days26549 535.5%  
Debtors Days Days25139 641.4%  
Net fixed assets Rs m17,3472,061 841.5%   
Share capital Rs m16650 331.8%   
"Free" reserves Rs m19,6555,811 338.2%   
Net worth Rs m19,8205,861 338.2%   
Long term debt Rs m60-   
Total assets Rs m31,79611,421 278.4%  
Interest coverage x64.1213.9 30.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.9 63.9%   
Return on assets %6.28.7 71.1%  
Return on equity %9.816.9 57.7%  
Return on capital %13.223.0 57.5%  
Exports to sales %00-   
Imports to sales %8.537.4 22.7%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m1,5093,747 40.3%   
Fx inflow Rs m3,259612 532.5%   
Fx outflow Rs m1,5093,747 40.3%   
Net fx Rs m1,749-3,135 -55.8%   
CASH FLOW
From Operations Rs m1,549583 265.8%  
From Investments Rs m111181 61.5%  
From Financial Activity Rs m-1,800-245 735.1%  
Net Cashflow Rs m-138519 -26.7%  

Share Holding

Indian Promoters % 69.7 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 10.2 5.4 188.0%  
FIIs % 2.4 2.7 91.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.3 25.0 121.4%  
Shareholders   55,341 29,032 190.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on FDC vs ASTRAZENECA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

FDC vs ASTRAZENECA PHARMA Share Price Performance

Period FDC ASTRAZENECA PHARMA S&P BSE HEALTHCARE
1-Day 1.06% 0.01% 1.18%
1-Month -4.50% -3.61% -0.75%
1-Year 69.82% 59.20% 61.82%
3-Year CAGR 14.77% 20.50% 18.16%
5-Year CAGR 20.71% 22.18% 19.79%

* Compound Annual Growth Rate

Here are more details on the FDC share price and the ASTRAZENECA PHARMA share price.

Moving on to shareholding structures...

The promoters of FDC hold a 69.7% stake in the company. In case of ASTRAZENECA PHARMA the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of FDC and the shareholding pattern of ASTRAZENECA PHARMA.

Finally, a word on dividends...

In the most recent financial year, FDC paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

ASTRAZENECA PHARMA paid Rs 16.0, and its dividend payout ratio stood at 40.3%.

You may visit here to review the dividend history of FDC, and the dividend history of ASTRAZENECA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.